Hypertension Channel
Related Channels

Afeditab and Breastfeeding

If you are taking Afeditab CR and breastfeeding at the same time, it is important to know that the medication does pass through your breast milk in low amounts. Although the manufacturer of Afeditab CR does not recommend that women take the medication when breastfeeding, many sources report that taking the medication while breastfeeding is probably safe.

Afeditab and Breastfeeding: An Overview

Afeditab CR® (nifedipine) is passed through breast milk. Because of the potentially serious side effects that could occur in the nursing infant, the manufacturer of Afeditab CR does not recommend that women take the medication when breastfeeding. Therefore, make sure to let your healthcare provider know if you are breastfeeding or thinking of breastfeeding.

Afeditab and Breastfeeding: What Does the Research Say?

Afeditab CR is passed through breast milk in low amounts. However, in documented cases of women using Afeditab CR during breastfeeding, no harmful effects were seen in the infants. Therefore, many sources report that Afeditab CR is probably compatible with breastfeeding.

Talking With Your Healthcare Provider About Afeditab and Breastfeeding

You should talk with your healthcare provider about Afeditab CR and breastfeeding. This is because everyone's situation is different, and your healthcare provider understands your situation best. Based on what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Afeditab CR and breastfeeding in your particular situation.
Baby Milestones You've Never Heard Of

Afeditab CR Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.